Patents by Inventor Sandrine Marchais

Sandrine Marchais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIARYL DERIVATIVES AS SELECTIVE 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 INHIBITORS
    Publication number: 20140057953
    Abstract: The invention relates to selective, non-steroidal 17beta-hydroxysteroid dehydrogenase type 2 (l7beta-HSD2) inhibitors of formula (I), their production and use, notably for the treatment and prophylaxis of sex steroid deficient diseases like osteoporosis in men and women.
    Type: Application
    Filed: March 2, 2012
    Publication date: February 27, 2014
    Inventors: Rolf Hartmann, Sandrine Marchais-Oberwinkler, Kuiying Xu, Ruth Werth
  • NEW APORPHINE ESTERS AND THEIR USE IN THERAPY
    Publication number: 20080119504
    Abstract: New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivates are also disclosed.
    Type: Application
    Filed: January 29, 2008
    Publication date: May 22, 2008
    Applicant: AXON BIOCHEMICALS B.V.
    Inventors: Hakan WIKSTROM, Durk Dijkstra, Thomas Cremers, Per Andren, Sandrine Marchais, Ulrik Jurva
  • Aporphine esters and their use in therapy
    Patent number: 7332503
    Abstract: New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
    Type: Grant
    Filed: February 22, 2005
    Date of Patent: February 19, 2008
    Assignee: Axon Biochemicals B.V.
    Inventors: Hakan Wikstrom, Durk Dijkstra, Thomas Cremers, Per Erik Andren, Sandrine Marchais, Ulrik Jurva
  • Aporphine esters and their use in therapy
    Patent number: 7238705
    Abstract: New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
    Type: Grant
    Filed: July 20, 2001
    Date of Patent: July 3, 2007
    Assignee: Axon Biochemicals B.V.
    Inventors: Hakan Wikstrom, Durk Dijkstra, Thomas Cremers, Per Erik Andren, Sandrine Marchais, Ulrik Jurva
  • Aporphine esters and their use in therapy
    Publication number: 20050143408
    Abstract: New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
    Type: Application
    Filed: February 22, 2005
    Publication date: June 30, 2005
    Applicant: AXON BIOCHEMICALS B.V.
    Inventors: Hakan Wikstrom, Durk Dijkstra, Thomas Cremers, Per Andren, Sandrine Marchais, Ulrik Jurva
  • Aporphine esters and their use in therapy
    Publication number: 20040018956
    Abstract: New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
    Type: Application
    Filed: July 15, 2003
    Publication date: January 29, 2004
    Inventors: Hakan Wikstrom, Durk Dijkstra, Thomas Cremers, Per Erik Andren, Sandrine Marchais, Ulrik Jurva